Across TCGA pan-cancer cohorts, UHRF1BP1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated UHRF1BP1 data layer compared with 26 for mass-spec protein and 8 for mutation status.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher UHRF1BP1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated UHRF1BP1 expression acts as an unfavorable survival marker, although some lineages such as UCEC and HNSC show a favorable association.
UCEC, PDAC, and HNSC are the cancer types where UHRF1BP1 mass-spec protein most reproducibly stratifies survival.